US Stock MarketDetailed Quotes

IOVA Iovance Biotherapeutics

Watchlist

9.370
-0.220-2.29%

Close Oct 16 16:00 ET

9.370
0.0000.00%

Post 19:58 ET

2.84BMarket Cap-5610P/E (TTM)

Iovance Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-4.77%-98.43M

-22.51%-122.28M

-23.59%-361.82M

-8.11%-83.97M

-32.10%-84.08M

-21.02%-93.95M

-35.25%-99.82M

-28.44%-292.76M

-44.24%-77.67M

-10.32%-63.65M

Net income from continuing operations

8.85%-97.1M

-5.22%-112.98M

-12.16%-444.04M

-10.50%-116.38M

-14.20%-113.76M

-7.23%-106.53M

-17.21%-107.37M

-15.67%-395.89M

-6.03%-105.32M

-15.67%-99.62M

Operating gains losses

--10K

---96K

--70K

---106K

--357K

----

Depreciation and amortization

38.55%10.86M

73.90%9.91M

56.74%33.13M

70.21%9.71M

89.83%9.88M

49.41%7.84M

14.44%5.7M

51.18%21.14M

27.84%5.71M

31.20%5.2M

Deferred tax

-205.66%-1.46M

---1.41M

---3.48M

---1.76M

---1.24M

---477K

--0

Change In working capital

-237.50%-38.71M

-153.71%-32.55M

-125.48%-6.52M

295.87%11.89M

-45.73%5.89M

-77.66%-11.47M

-24.64%-12.83M

-111.78%-2.89M

-85.75%3M

182.44%10.85M

-Change in receivables

-94,960.61%-31.37M

---83K

---149K

----

---33K

--0

----

-Change in inventory

7.23%-8.86M

---6.74M

---10.12M

---923K

--354K

---9.55M

--0

-Change in prepaid assets

92.55%-211K

239.16%5.89M

-372.39%-10.06M

-280.89%-5.15M

192.92%2.15M

-368.88%-2.83M

-13.89%-4.23M

-176.76%-2.13M

26.04%2.85M

-165.12%-2.32M

-Change in payables and accrued expense

21.44%4.42M

-378.19%-28.83M

1,984.92%24.6M

744.95%20.83M

-55.02%6.17M

147.11%3.64M

17.05%-6.03M

-95.73%1.18M

-87.24%2.47M

391.75%13.71M

-Change in other current liabilities

0.11%-2.69M

-8.56%-2.79M

-455.82%-10.79M

-17.85%-2.72M

-424.81%-2.81M

-1,369.81%-2.69M

-472.32%-2.57M

66.98%-1.94M

-368.15%-2.31M

78.55%-536K

Cash from discontinued investing activities

Operating cash flow

-4.77%-98.43M

-22.51%-122.28M

-23.59%-361.82M

-8.11%-83.97M

-32.10%-84.08M

-21.02%-93.95M

-35.25%-99.82M

-28.44%-292.76M

-44.24%-77.67M

-10.32%-63.65M

Investing cash flow

Cash flow from continuing investing activities

125.65%40.22M

-172.69%-111.51M

-160.53%-155.24M

-15,901.52%-72.85M

-207.19%-79.01M

-263.72%-156.78M

77.30%153.4M

194,184.09%256.46M

-99.34%461K

478.25%73.72M

Net PPE purchase and sale

95.36%-442K

26.36%-4.17M

-9.13%-22.29M

-16.78%-3.53M

-157.89%-3.58M

-108.04%-9.52M

50.49%-5.66M

45.64%-20.43M

60.07%-3.02M

85.68%-1.39M

Net business purchase and sale

--0

---52.57M

---212.63M

--253K

---3.38M

---209.51M

--0

Net investment purchase and sale

-34.68%40.66M

-134.43%-54.76M

-71.22%79.68M

-2,097.39%-69.57M

-195.95%-72.06M

-37.96%62.25M

62.38%159.06M

634.31%276.88M

-95.47%3.48M

234.78%75.1M

Cash from discontinued investing activities

Investing cash flow

125.65%40.22M

-172.69%-111.51M

-160.53%-155.24M

-15,901.52%-72.85M

-207.19%-79.01M

-263.72%-156.78M

77.30%153.4M

194,184.09%256.46M

-99.34%461K

478.25%73.72M

Financing cash flow

Cash flow from continuing financing activities

14,809.76%152.83M

-25.02%193.58M

143.47%462.96M

-99.50%962K

90,033.33%202.8M

149.59%1.03M

18,119.62%258.17M

-20.53%190.15M

4,492.17%190.58M

-98.92%225K

Net issuance payments of debt

----

--0

----

--0

----

Net common stock issuance

--151.87M

-23.91%197.91M

144.47%463.28M

-100.00%1K

--203.18M

--0

--260.1M

-6.72%189.5M

--189.5M

--0

Proceeds from stock option exercised by employees

47.21%1.95M

--364K

-24.99%2.47M

6.90%1.15M

--0

127.84%1.33M

--0

-90.61%3.3M

-74.14%1.07M

-98.92%225K

Net other financing activities

-232.23%-1M

-143.70%-4.7M

-5.51%-2.8M

---186K

---379K

---301K

---1.93M

---2.65M

--0

Cash from discontinued financing activities

Financing cash flow

14,809.76%152.83M

-25.02%193.58M

143.47%462.96M

-99.50%962K

90,033.33%202.8M

149.59%1.03M

18,119.62%258.17M

-20.53%190.15M

4,492.17%190.58M

-98.92%225K

Net cash flow

Beginning cash position

-74.43%140.62M

-23.87%181.32M

182.47%238.16M

167.76%334.15M

158.89%296.44M

458.61%549.91M

182.47%238.16M

15.73%84.31M

92.96%124.8M

28.88%114.51M

Current changes in cash

137.89%94.62M

-112.90%-40.21M

-135.17%-54.1M

-237.48%-155.85M

285.80%39.7M

-1,654.74%-249.71M

2,106.16%311.75M

1,242.60%153.85M

477.24%113.37M

142.57%10.29M

Effect of exchange rate changes

96.68%-125K

---491K

---2.74M

--3.02M

---1.99M

---3.77M

--0

----

--0

End cash Position

-20.69%235.11M

-74.43%140.62M

-23.87%181.32M

167.76%334.15M

158.89%296.44M

458.61%549.91M

182.47%238.16M

92.96%124.8M

Free cash flow

4.45%-98.87M

-19.88%-126.45M

-22.65%-384.11M

-8.43%-87.5M

-34.79%-87.66M

-25.86%-103.47M

-23.74%-105.48M

-17.95%-313.18M

-31.39%-80.69M

3.48%-65.04M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-4.77%-98.43M	-22.51%-122.28M	-23.59%-361.82M	-8.11%-83.97M	-32.10%-84.08M	-21.02%-93.95M	-35.25%-99.82M	-28.44%-292.76M	-44.24%-77.67M	-10.32%-63.65M
Net income from continuing operations	8.85%-97.1M	-5.22%-112.98M	-12.16%-444.04M	-10.50%-116.38M	-14.20%-113.76M	-7.23%-106.53M	-17.21%-107.37M	-15.67%-395.89M	-6.03%-105.32M	-15.67%-99.62M
Operating gains losses	--10K	---96K	--70K	---106K	--357K	----	----	----	----	----
Depreciation and amortization	38.55%10.86M	73.90%9.91M	56.74%33.13M	70.21%9.71M	89.83%9.88M	49.41%7.84M	14.44%5.7M	51.18%21.14M	27.84%5.71M	31.20%5.2M
Deferred tax	-205.66%-1.46M	---1.41M	---3.48M	---1.76M	---1.24M	---477K	--0	--0	--0	--0
Change In working capital	-237.50%-38.71M	-153.71%-32.55M	-125.48%-6.52M	295.87%11.89M	-45.73%5.89M	-77.66%-11.47M	-24.64%-12.83M	-111.78%-2.89M	-85.75%3M	182.44%10.85M
-Change in receivables	-94,960.61%-31.37M	---83K	---149K	----	----	---33K	--0	--0	----	----
-Change in inventory	7.23%-8.86M	---6.74M	---10.12M	---923K	--354K	---9.55M	--0	--0	--0	--0
-Change in prepaid assets	92.55%-211K	239.16%5.89M	-372.39%-10.06M	-280.89%-5.15M	192.92%2.15M	-368.88%-2.83M	-13.89%-4.23M	-176.76%-2.13M	26.04%2.85M	-165.12%-2.32M
-Change in payables and accrued expense	21.44%4.42M	-378.19%-28.83M	1,984.92%24.6M	744.95%20.83M	-55.02%6.17M	147.11%3.64M	17.05%-6.03M	-95.73%1.18M	-87.24%2.47M	391.75%13.71M
-Change in other current liabilities	0.11%-2.69M	-8.56%-2.79M	-455.82%-10.79M	-17.85%-2.72M	-424.81%-2.81M	-1,369.81%-2.69M	-472.32%-2.57M	66.98%-1.94M	-368.15%-2.31M	78.55%-536K
Cash from discontinued investing activities
Operating cash flow	-4.77%-98.43M	-22.51%-122.28M	-23.59%-361.82M	-8.11%-83.97M	-32.10%-84.08M	-21.02%-93.95M	-35.25%-99.82M	-28.44%-292.76M	-44.24%-77.67M	-10.32%-63.65M
Investing cash flow
Cash flow from continuing investing activities	125.65%40.22M	-172.69%-111.51M	-160.53%-155.24M	-15,901.52%-72.85M	-207.19%-79.01M	-263.72%-156.78M	77.30%153.4M	194,184.09%256.46M	-99.34%461K	478.25%73.72M
Net PPE purchase and sale	95.36%-442K	26.36%-4.17M	-9.13%-22.29M	-16.78%-3.53M	-157.89%-3.58M	-108.04%-9.52M	50.49%-5.66M	45.64%-20.43M	60.07%-3.02M	85.68%-1.39M
Net business purchase and sale	--0	---52.57M	---212.63M	--253K	---3.38M	---209.51M	--0	--0	--0	--0
Net investment purchase and sale	-34.68%40.66M	-134.43%-54.76M	-71.22%79.68M	-2,097.39%-69.57M	-195.95%-72.06M	-37.96%62.25M	62.38%159.06M	634.31%276.88M	-95.47%3.48M	234.78%75.1M
Cash from discontinued investing activities
Investing cash flow	125.65%40.22M	-172.69%-111.51M	-160.53%-155.24M	-15,901.52%-72.85M	-207.19%-79.01M	-263.72%-156.78M	77.30%153.4M	194,184.09%256.46M	-99.34%461K	478.25%73.72M
Financing cash flow
Cash flow from continuing financing activities	14,809.76%152.83M	-25.02%193.58M	143.47%462.96M	-99.50%962K	90,033.33%202.8M	149.59%1.03M	18,119.62%258.17M	-20.53%190.15M	4,492.17%190.58M	-98.92%225K
Net issuance payments of debt	----	----	--0	----	----	----	----	--0	----	----
Net common stock issuance	--151.87M	-23.91%197.91M	144.47%463.28M	-100.00%1K	--203.18M	--0	--260.1M	-6.72%189.5M	--189.5M	--0
Proceeds from stock option exercised by employees	47.21%1.95M	--364K	-24.99%2.47M	6.90%1.15M	--0	127.84%1.33M	--0	-90.61%3.3M	-74.14%1.07M	-98.92%225K
Net other financing activities	-232.23%-1M	-143.70%-4.7M	-5.51%-2.8M	---186K	---379K	---301K	---1.93M	---2.65M	--0	--0
Cash from discontinued financing activities
Financing cash flow	14,809.76%152.83M	-25.02%193.58M	143.47%462.96M	-99.50%962K	90,033.33%202.8M	149.59%1.03M	18,119.62%258.17M	-20.53%190.15M	4,492.17%190.58M	-98.92%225K
Net cash flow
Beginning cash position	-74.43%140.62M	-23.87%181.32M	182.47%238.16M	167.76%334.15M	158.89%296.44M	458.61%549.91M	182.47%238.16M	15.73%84.31M	92.96%124.8M	28.88%114.51M
Current changes in cash	137.89%94.62M	-112.90%-40.21M	-135.17%-54.1M	-237.48%-155.85M	285.80%39.7M	-1,654.74%-249.71M	2,106.16%311.75M	1,242.60%153.85M	477.24%113.37M	142.57%10.29M
Effect of exchange rate changes	96.68%-125K	---491K	---2.74M	--3.02M	---1.99M	---3.77M	--0	----	----	--0
End cash Position	-20.69%235.11M	-74.43%140.62M	-23.87%181.32M	-23.87%181.32M	167.76%334.15M	158.89%296.44M	458.61%549.91M	182.47%238.16M	182.47%238.16M	92.96%124.8M
Free cash flow	4.45%-98.87M	-19.88%-126.45M	-22.65%-384.11M	-8.43%-87.5M	-34.79%-87.66M	-25.86%-103.47M	-23.74%-105.48M	-17.95%-313.18M	-31.39%-80.69M	3.48%-65.04M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data